RE: X-O Share Allocation2 Mar 2021 17:45
I got 5.7333% of my substantial XS application i.e. a little less the 1:17 offer. Disappointing but better than nothing. As others have implied, now comes an acid test for this company. It has products of undoubted potential; it is now empowered with the cash to drive forward and realise that potential. Small investors have been very patient (& in this offer) disadvantaged relative to Directors & Institutional Investors. If substantive progress is not made this time, I'm inclined to think many might call it a day and put their money into other innovative biotech companies with the capacity & experience to deliver the promise that r-dna technology really can provide. Even IC's ST might lose heart!